Hugel is a South Korea-based global leader in medical aesthetics founded in 2001, specializing in the development and commercialization of botulinum toxin, hyaluronic acid fillers, skin boosters, threads, and biocosmetics. With commercial presence in approximately 70 countries and nine international subsidiaries, Hugel has established a strong global footprint. Hugel Aesthetics serves as the company's dedicated North American business unit, focused on expanding access to products like Letybo and establishing a strong, long-term presence in the medical aesthetics market across the United States, Canada, and Australia. The organization is characterized by a customer-focused approach rooted in high ownership, collaboration, and a commitment to earning trust through science, transparency, and integrity.
Industry
Medical Aesthetics
Company Size
1001-5000 employees
Founded
2001
Beta · Sourced from candidate reports
Be the first to share your experience with Hugel Aesthetics.
Your reply helps other candidates know what to expect.
